{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:41:59Z","timestamp":1766158919900,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-022-05616-7","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T07:02:44Z","timestamp":1646722964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic polymorphisms of apolipoprotein E in nonarteritic anterior ischemic optic neuropathy"],"prefix":"10.1007","author":[{"given":"Yuyu","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9511-4726","authenticated-orcid":false,"given":"Yong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"5616_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","volume":"28","author":"SS Hayreh","year":"2009","unstructured":"Hayreh SS (2009) Ischemic optic neuropathy. Prog Retin Eye Res 28:34\u201362. https:\/\/doi.org\/10.1016\/j.preteyeres.2008.11.002","journal-title":"Prog Retin Eye Res"},{"key":"5616_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/eye.2014.144","volume":"29","author":"NR Miller","year":"2015","unstructured":"Miller NR, Arnold AC (2015) Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye (Lond) 29:65\u201379. https:\/\/doi.org\/10.1038\/eye.2014.144","journal-title":"Eye (Lond)"},{"key":"5616_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3980\/j.issn.2222-3959.2011.03.12","volume":"4","author":"A Bawazir","year":"2011","unstructured":"Bawazir A, Gharebaghi R, Hussein A, Hazabbah WHW (2011) Non-arteritic anterior ischaemic optic neuropathy in Malaysia: a 5 years review. Int J Ophthalmol 4:272\u2013274. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2011.03.12","journal-title":"Int J Ophthalmol"},{"key":"5616_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ophtha.2007.05.027","volume":"115","author":"SS Hayreh","year":"2008","unstructured":"Hayreh SS, Zimmerman MB (2008) Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 115:298\u2013305. https:\/\/doi.org\/10.1016\/j.ophtha.2007.05.027","journal-title":"Ophthalmology"},{"key":"5616_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.31348\/2020\/15","volume":"76","author":"S Kal\u00e1bov\u00e1","year":"2020","unstructured":"Kal\u00e1bov\u00e1 S, Mare\u0161ov\u00e1 K, Karhanov\u00e1 M (2020) Non-arteritic anterior ischaemic optic neuropathy: treatment and risk factors. Cesk Slov Oftalmol 76:78\u201387. https:\/\/doi.org\/10.31348\/2020\/15","journal-title":"Cesk Slov Oftalmol"},{"key":"5616_CR6","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.ophtha.2016.08.017","volume":"123","author":"DM Cestari","year":"2016","unstructured":"Cestari DM, Gaier ED, Bouzika P, Blachley TS, De Lott LB, Rizzo JF, Wiggs JL, Kang JH, Pasquale LR, Stein JD (2016) Demographic, systemic, and ocular factors associated with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 123:2446\u20132455. https:\/\/doi.org\/10.1016\/j.ophtha.2016.08.017","journal-title":"Ophthalmology"},{"key":"5616_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/s0002-9394(14)73478-6","volume":"116","author":"RM Burde","year":"1993","unstructured":"Burde RM (1993) Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 116:759\u2013764. https:\/\/doi.org\/10.1016\/s0002-9394(14)73478-6","journal-title":"Am J Ophthalmol"},{"key":"5616_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1167\/iovs.62.4.42","volume":"62","author":"E Augstburger","year":"2021","unstructured":"Augstburger E, Ballino A, Keilani C, Robin M, Baudouin C, Labb\u00e9 A (2021) Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 62:42. https:\/\/doi.org\/10.1167\/iovs.62.4.42","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5616_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/archopht.124.5.696","volume":"124","author":"V Purvin","year":"2006","unstructured":"Purvin V, Kawasaki A, Borruat FX (2006) Optic neuropathy in patients using amiodarone. Arch Ophthalmol 124:696\u2013701. https:\/\/doi.org\/10.1001\/archopht.124.5.696","journal-title":"Arch Ophthalmol"},{"key":"5616_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WNO.0000000000000299","volume":"36","author":"HD Pomeranz","year":"2016","unstructured":"Pomeranz HD (2016) The relationship between phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 36:193\u2013196. https:\/\/doi.org\/10.1097\/WNO.0000000000000299","journal-title":"J Neuroophthalmol"},{"key":"5616_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00417-008-0853-0","volume":"246","author":"SS Hayreh","year":"2008","unstructured":"Hayreh SS, Fingert JH, Stone E, Jacobson DM (2008) Familial non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 246:1295\u20131305. https:\/\/doi.org\/10.1007\/s00417-008-0853-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5616_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13816810701199399","volume":"28","author":"JH Fingert","year":"2007","unstructured":"Fingert JH, Grassi MA, Janutka JC, East JS, Howard JG, Sheffield VC, Jacobson DM, Hayreh SS, Stone EM (2007) Mitochondrial variant g4132a is associated with familial non-arteritic anterior ischemic optic neuropathy in one large pedigree. Ophthalmic Genet 28:1\u20137. https:\/\/doi.org\/10.1080\/13816810701199399","journal-title":"Ophthalmic Genet"},{"key":"5616_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00417-010-1308-y","volume":"248","author":"T Felekis","year":"2010","unstructured":"Felekis T, Kolaitis NI, Kitsos G, Vartholomatos G, Bourantas KL, Asproudis I (2010) Thrombophilic risk factors in the pathogenesis of non-arteritic anterior ischemic optic neuropathy patients. Graefes Arch Clin Exp Ophthalmol 248:877\u2013884. https:\/\/doi.org\/10.1007\/s00417-010-1308-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5616_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ophtha.2003.05.006","volume":"111","author":"O Salomon","year":"2004","unstructured":"Salomon O, Rosenberg N, Steinberg DM, Huna-Baron R, Moisseiev J, Dardik R, Goldan O, Kurtz S, Ifrah A, Seligsohn U (2004) Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein ibalpha gene. Ophthalmology 111:184\u2013188. https:\/\/doi.org\/10.1016\/j.ophtha.2003.05.006","journal-title":"Ophthalmology"},{"key":"5616_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1017\/S0952523810000350","volume":"27","author":"S Giannopoulos","year":"2010","unstructured":"Giannopoulos S, Markoula S, Asproudis I, Galidi A, Nikas A, Kyritsis AP, Georgiou I (2010) Endothelial nitric oxide synthase polymorphism (g894t) and nonarteritic anterior ischemic optic neuropathy. Vis Neurosci 27:183\u2013185. https:\/\/doi.org\/10.1017\/S0952523810000350","journal-title":"Vis Neurosci"},{"key":"5616_CR16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/s0161-6420(00)00220-7","volume":"107","author":"O Salomon","year":"2000","unstructured":"Salomon O, Dardik R, Steinberg DM, Kurtz S, Rosenberg N, Moisseiev J, Huna-Baron R (2000) The role of angiotensin converting enzyme and angiotensin ii type 1 receptor gene polymorphisms in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 107:1717\u20131720. https:\/\/doi.org\/10.1016\/s0161-6420(00)00220-7","journal-title":"Ophthalmology"},{"key":"5616_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.exer.2018.05.021","volume":"174","author":"T Chen","year":"2018","unstructured":"Chen T, Ma J, Shan G, Zhong Y (2018) The polymorphisms of atoh 7, et-1 and ace in non-arteritic anterior ischemic optic neuropathy. Exp Eye Res 174:147\u2013151. https:\/\/doi.org\/10.1016\/j.exer.2018.05.021","journal-title":"Exp Eye Res"},{"key":"5616_CR18","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s12035-015-9185-3","volume":"53","author":"W Wan","year":"2016","unstructured":"Wan W, Peng T, Jin X, Li Q, Zhang F, Zheng G, Lv Y, Wan G, Zhu Y (2016) Glutathione-s-transferase deletions and non-arteritic anterior ischemic optic neuropathy. Mol Neurobiol 53:2361\u20132367. https:\/\/doi.org\/10.1007\/s12035-015-9185-3","journal-title":"Mol Neurobiol"},{"key":"5616_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall SJ (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507\u2013537. https:\/\/doi.org\/10.1146\/annurev.genom.1.1.507","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"5616_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23925","volume":"35","author":"Q Liu","year":"2021","unstructured":"Liu Q, Wu H, Yu Z, Huang Q, Zhong Z (2021) Apoe gene \u025b4 allele (388c\u2013526c) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population. J Clin Lab Anal 35:e23925. https:\/\/doi.org\/10.1002\/jcla.23925","journal-title":"J Clin Lab Anal"},{"key":"5616_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley RW, Huang Y (2012) Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron 76:871\u2013885. https:\/\/doi.org\/10.1016\/j.neuron.2012.11.020","journal-title":"Neuron"},{"key":"5616_CR22","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1001\/archopht.1996.01100140566007","volume":"114","author":"NJ Newman","year":"1996","unstructured":"Newman NJ, Dickersin K, Kaufman D, Kelman S, Scherer R (1996) Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial. Arch Ophthalmol 114:1366\u20131374. https:\/\/doi.org\/10.1001\/archopht.1996.01100140566007","journal-title":"Arch Ophthalmol"},{"key":"5616_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.arcmed.2017.08.002","volume":"48","author":"M Xiying","year":"2017","unstructured":"Xiying M, Wenbo W, Wangyi F, Qinghuai L (2017) Association of apolipoprotein e polymorphisms with age-related macular degeneration subtypes: an updated systematic review and meta-analysis. Arch Med Res 48:370\u2013377. https:\/\/doi.org\/10.1016\/j.arcmed.2017.08.002","journal-title":"Arch Med Res"},{"key":"5616_CR24","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1007\/s11033-021-06581-w","volume":"48","author":"L Dlouha","year":"2021","unstructured":"Dlouha L, Pelikanova T, Veleba J, Adamkova V, Lanska V, Sosna T, Pacal L, Kankova K, Hubacek JA (2021) The apoe4 allele is associated with a decreased risk of retinopathy in type 2 diabetics. Mol Biol Rep 48:5873\u20135879. https:\/\/doi.org\/10.1007\/s11033-021-06581-w","journal-title":"Mol Biol Rep"},{"key":"5616_CR25","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1167\/iovs.11-9300","volume":"53","author":"D Aggarwal","year":"2012","unstructured":"Aggarwal D, Tan O, Huang D, Sadun AA (2012) Patterns of ganglion cell complex and nerve fiber layer loss in nonarteritic ischemic optic neuropathy by Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:4539\u20134545. https:\/\/doi.org\/10.1167\/iovs.11-9300","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5616_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jns.2016.12.044","volume":"375","author":"S Khalilpour","year":"2017","unstructured":"Khalilpour S, Latifi S, Behnammanesh G, Majid A, Majid A, Tamayol A (2017) Ischemic optic neuropathy as a model of neurodegenerative disorder: a review of pathogenic mechanism of axonal degeneration and the role of neuroprotection. J Neurol Sci 375:430\u2013441. https:\/\/doi.org\/10.1016\/j.jns.2016.12.044","journal-title":"J Neurol Sci"},{"key":"5616_CR27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3233\/JAD-210434","volume":"82","author":"XR Chen","year":"2021","unstructured":"Chen XR, Shao Y, Sadowski MJ (2021) Segmented linear mixed model analysis reveals association of the apoe\u025b4 allele with faster rate of Alzheimer\u2019s disease dementia progression. J Alzheimers Dis 82:921\u2013937. https:\/\/doi.org\/10.3233\/JAD-210434","journal-title":"J Alzheimers Dis"},{"key":"5616_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ymeth.2004.11.004","volume":"36","author":"B Karten","year":"2005","unstructured":"Karten B, Hayashi H, Campenot RB, Vance DE, Vance JE (2005) Neuronal models for studying lipid metabolism and transport. Methods 36:117\u2013128. https:\/\/doi.org\/10.1016\/j.ymeth.2004.11.004","journal-title":"Methods"},{"key":"5616_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00417-014-2572-z","volume":"53","author":"JF Cullen","year":"2012","unstructured":"Cullen JF, Chung SH (2012) Non-arteritic anterior ischaemic optic neuropathy (NA-AION): outcome for visual acuity and visual field defects, the Singapore scene 2. Singapore Med J 53:88\u201390. https:\/\/doi.org\/10.1007\/s00417-014-2572-z","journal-title":"Singapore Med J"},{"key":"5616_CR30","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00417-014-2697-0","volume":"252","author":"BA Larrea","year":"2014","unstructured":"Larrea BA, Iztueta MG, Indart LM, Alday NM (2014) Early axonal damage detection by ganglion cell complex analysis with optical coherence tomography in nonarteritic anterior ischaemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 252:1839\u20131846. https:\/\/doi.org\/10.1007\/s00417-014-2697-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5616_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00417-014-2572-z","volume":"252","author":"C Kernstock","year":"2014","unstructured":"Kernstock C, Beisse F, Wiethoff S, Mast A, Krapp E, Grund R, Dietzsch J, Lagr\u00e8ze W, Fischer D, Schiefer U (2014) Assessment of functional and morphometric endpoints in patients with non-arteritic anterior ischemic optic neuropathy (NAION). Graefes Arch Clin Exp Ophthalmol 252:515\u2013521. https:\/\/doi.org\/10.1007\/s00417-014-2572-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5616_CR32","doi-asserted-by":"publisher","first-page":"22358","DOI":"10.1016\/S0021-9258(17)31797-0","volume":"269","author":"LM Dong","year":"1994","unstructured":"Dong LM, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agard DA (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the e3 and e4 isoforms. J Biol Chem 269:22358\u201322365","journal-title":"J Biol Chem"},{"key":"5616_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G (2009) Apolipoprotein e and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333\u2013344. https:\/\/doi.org\/10.1038\/nrn2620","journal-title":"Nat Rev Neurosci"},{"key":"5616_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149227","volume":"6","author":"A Desimone","year":"2021","unstructured":"Desimone A, Hong J, Brockie ST, Yu W, Laliberte AM, Fehlings MG (2021) The influence of apoe4 on the clinical outcomes and pathophysiology of degenerative cervical myelopathy. JCI Insight 6:e149227. https:\/\/doi.org\/10.1172\/jci.insight.149227","journal-title":"JCI Insight"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05616-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05616-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05616-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T07:09:10Z","timestamp":1646723350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05616-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":34,"alternative-id":["5616"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05616-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is in accordance with the tenets of the Declaration of Helsinki. Its protocol was approved by the Institutional Review Board of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Written informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No financial disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclosures"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}